[1]
H. Zaghloul, “TARGETING CYCLIN B1 WITH ANTISENSE OLIGONUCLETOTIDES- COATED SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES”, Journal of Drug Discovery And Therapeutics, vol. 6, no. 10, Oct. 2018.